IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cadence Pharmaceuticals Inc

CUSIP: 12738T100 | 118 institutional holders

Quarters

Q1 2014Q4 2013Q3 2013Q2 2013Q1 2013
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2014

Omni Partners LLP250,000
5.2% of portfolio›$3.5K
Citigroup Inc13,052
0.0% of portfolio›$183
BlackRock Institutional Trust Company, N.A.6,178
0.0% of portfolio›$86
StyleTurnoverLocationFiled
Omni Partners LLP
250,000$3.5K5.2%N/AN/ALondon, United Kingdom2014-05-13
Citigroup Inc
13,052$1830.0%CoreMediumNew York, NY2014-05-15
BlackRock Institutional Trust Company, N.A.
6,178$860.0%N/AN/ASan Francisco, CA2014-05-02